10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 2, 2022 10-K (Filed: Feb 17, 2022) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Jan 2, 2022 | Jan 3, 2021 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 14,487 | 13,985 |
| Marketable securities (Notes 1 and 2) | 17,121 | 11,200 |
| Accounts receivable trade, less allowances for doubtful accounts $230 (2020, $293) | 15,283 | 13,576 |
| Inventories (Notes 1 and 3) | 10,387 | 9,344 |
| Prepaid expenses and other receivables | 3,701 | 3,132 |
| Total current assets | 60,979 | 51,237 |
| Property, plant and equipment, net (Notes 1 and 4) | 18,962 | 18,766 |
| Intangible assets, net (Notes 1 and 5) | 46,392 | 53,402 |
| Goodwill (Notes 1 and 5) | 35,246 | 36,393 |
| Deferred taxes on income (Note 8) | 10,223 | 8,534 |
| Other assets | 10,216 | 6,562 |
| Total assets | 182,018 | 174,894 |
| Liabilities and Shareholders Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | 3,766 | 2,631 |
| Accounts payable | 11,055 | 9,505 |
| Accrued liabilities | 13,612 | 13,968 |
| Accrued rebates, returns and promotions | 12,095 | 11,513 |
| Accrued compensation and employee related obligations | 3,586 | 3,484 |
| Accrued taxes on income (Note 8) | 1,112 | 1,392 |
| Total current liabilities | 45,226 | 42,493 |
| Long-term debt (Note 7) | 29,985 | 32,635 |
| Deferred taxes on income (Note 8) | 7,487 | 7,214 |
| Employee related obligations (Notes 9 and 10) | 8,898 | 10,771 |
| Long-term taxes payable (Note 1) | 5,713 | 6,559 |
| Other liabilities | 10,686 | 11,944 |
| Total liabilities | 107,995 | 111,616 |
| Commitments and Contingencies (Note 19) | ||
| Shareholders equity | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (13,058) | (15,242) |
| Retained earnings | 123,060 | 113,890 |
| Stockholders' Equity before Treasury Stock | 113,122 | 101,768 |
| Less: common stock held in treasury, at cost (Note 12) (490,878,000 shares and 487,331,000 shares) | 39,099 | 38,490 |
| Total shareholders equity | 74,023 | 63,278 |
| Total liabilities and shareholders equity | 182,018 | 174,894 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |